| Ident. | Authors (with country if any) | Title |
|---|
| 000144 (2020) |
James M. Dittman [États-Unis] ; Wayne Tse [États-Unis] ; Michael F. Amendola [États-Unis] | Optimizing Peripandemic Care for Veteran Major Non-Traumatic Lower Extremity Amputees: A Proposal Informed by a National Retrospective Descriptive Analysis of COVID-19 Risk Factor Prevalence. |
| 000149 (2020) |
Naveed Sattar [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] ; John J V. Mcmurray [Royaume-Uni] | Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. |
| 000153 (2020) |
Alvaro Lorente-Ros [Espagne] ; Juan Manuel Monteagudo Ruiz [Espagne] ; Luis M. Rinc N [Espagne] ; Rodrigo Ortega Pérez [Espagne] ; Sonia Rivas [Espagne] ; Rafael Martínez-Moya [Espagne] ; Maria Ascensi N Sanromán [Espagne] ; Luis Manzano [Espagne] ; Gonzalo Luis Alonso [Espagne] ; Borja Ibá Ez [Espagne] ; Jose Luis Zamorano [Espagne] | Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. |
| 000159 (2020) |
Bradley Field Bale [États-Unis] ; Amy Lynn Doneen [États-Unis] ; David John Vigerust [États-Unis] | Microvascular disease confers additional risk to COVID-19 infection. |
| 000161 (2020) |
Praveen Sharma [Inde] ; Ashish Kumar [Inde] | Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. |
| 000173 (2020) |
Mark Hamer [Royaume-Uni] ; Mika Kivim Ki [Royaume-Uni] ; Catharine R. Gale [Royaume-Uni] ; G David Batty [Royaume-Uni] | Lifestyle Risk Factors for Cardiovascular Disease in Relation to COVID-19 Hospitalization: A Community-Based Cohort Study of 387,109 Adults in UK. |
| 000177 (2020) |
Antonio Ceriello [Italie] ; Eberhard Standl [Allemagne] ; Doina Catrinoiu [Roumanie] ; Baruch Itzhak [Israël] ; Nebojsa M. Lalic [Serbie] ; Dario Rahelic [Croatie] ; Oliver Schnell [Allemagne] ; Jan Škrha [République tchèque] ; Paul Valensi | Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. |
| 000198 (2020) |
Andrew Clark [Royaume-Uni] ; Mark Jit [Royaume-Uni] ; Charlotte Warren-Gash [Royaume-Uni] ; Bruce Guthrie [Royaume-Uni] ; Harry H X. Wang [République populaire de Chine] ; Stewart W. Mercer [Royaume-Uni] ; Colin Sanderson [Royaume-Uni] ; Martin Mckee [Royaume-Uni] ; Christopher Troeger [États-Unis] ; Kanyin L. Ong [États-Unis] ; Francesco Checchi [Royaume-Uni] ; Pablo Perel [Royaume-Uni] ; Sarah Joseph [Royaume-Uni] ; Hamish P. Gibbs [Royaume-Uni] ; Amitava Banerjee [Royaume-Uni] ; Rosalind M. Eggo [Royaume-Uni] | Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. |
| 000207 (2020) |
Hilda Razzaghi ; Yan Wang ; Hua Lu ; Katherine E. Marshall ; Nicole F. Dowling ; Gabriela Paz-Bailey ; Evelyn R. Twentyman ; Georgina Peacock ; Kurt J. Greenlund | Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018. |
| 000219 (2020) |
Bolin Wang [République populaire de Chine] ; Ruobao Li [République populaire de Chine] ; Zhong Lu [République populaire de Chine] ; Yan Huang [République populaire de Chine] | Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. |
| 000227 (2020) |
Yiwu Zhou [République populaire de Chine] ; Yanqi He [République populaire de Chine] ; Huan Yang [République populaire de Chine] ; He Yu [République populaire de Chine] ; Ting Wang [République populaire de Chine] ; Zhu Chen [République populaire de Chine] ; Rong Yao [République populaire de Chine] ; Zongan Liang [République populaire de Chine] | Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China. |
| 000235 (2020) |
Francesco P. Cappuccio [Royaume-Uni] ; Alfonso Siani [Italie] | Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint. |
| 000259 (2020) |
Yue Zhou [République populaire de Chine] ; Qing Yang [République populaire de Chine] ; Jingwei Chi [République populaire de Chine] ; Bingzi Dong [République populaire de Chine] ; Wenshan Lv [République populaire de Chine] ; Liyan Shen [République populaire de Chine] ; Yangang Wang [République populaire de Chine] | Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. |
| 000279 (2020) |
Qiao Shi [République populaire de Chine] ; Xiaoyi Zhang [République populaire de Chine] ; Fang Jiang [République populaire de Chine] ; Xuanzhe Zhang [République populaire de Chine] ; Ning Hu [République populaire de Chine] ; Chibu Bimu [République populaire de Chine] ; Jiarui Feng [République populaire de Chine] ; Su Yan [République populaire de Chine] ; Yongjun Guan [République populaire de Chine] ; Dongxue Xu [République populaire de Chine] ; Guangzhen He [République populaire de Chine] ; Chen Chen [République populaire de Chine] ; Xingcheng Xiong [République populaire de Chine] ; Lei Liu [République populaire de Chine] ; Hanjun Li [République populaire de Chine] ; Jing Tao [République populaire de Chine] ; Zhiyong Peng [Oman] ; Weixing Wang [Oman] | Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. |
| 000292 (2020) |
Leili Rahimi [États-Unis] ; Mojtaba Malek [Iran] ; Faramarz Ismail-Beigi [États-Unis] ; Mohammad E. Khamseh [Iran] | Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. |
| 000299 (2020) |
Sara Momtazmanesh [Iran] ; Parnian Shobeiri [Iran] ; Sara Hanaei [Iran] ; Hani Mahmoud-Elsayed [Royaume-Uni] ; Bharat Dalvi [Inde] ; Elaheh Malakan Rad [Iran] | Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. |
| 000301 (2020) |
Seshadri Reddy Varikasuvu [Inde] ; Naveen Dutt [Inde] | Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot. |
| 000302 (2020) |
Nicola Ielapi [Italie] ; Noemi Licastro [Italie] ; Michele Provenzano [Italie] ; Michele Andreucci [Italie] ; Stefano De Franciscis [Italie] ; Raffaele Serra [Italie] | Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. |
| 000320 (2020) |
Ghazal Aghagoli [États-Unis] ; Benjamin Gallo Marin [États-Unis] ; Luke B. Soliman [États-Unis] ; Frank W. Sellke [États-Unis] | Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. |
| 000321 (2020) |
Kunal Mahajan [Inde] ; Prakash Chand Negi [Inde] ; Neeraj Ganju [Inde] ; Sanjeev Asotra [Inde] | Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19. |
| 000337 (2020) |
Anna Vittoria Mattioli [Italie] ; Matteo Ballerini Puviani [Italie] ; Milena Nasi [Italie] ; Alberto Farinetti [Italie] | COVID-19 pandemic: the effects of quarantine on cardiovascular risk. |
